Home NRBO
0.805
  Price2.72%   -0.0225
(After Hours: .81 +0.005 +0.62% )
loading

Neurobo Pharmaceuticals (NRBO) Options Chain

Calls Options of NRBO for 2023-03-17 (Expired in 37 days)

Strike Price Change % Change Volume
favorite 0 0.00 0.00 0.00% 0
favorite 0 0.00 0.00 0.00% 0
favorite 0 0.00 0.00 0.00% 0
favorite 2.50 0.21 0.00 0.00% 0
favorite 5.00 0.00 0.00 0.00% 0
favorite 7.50 0.00 0.00 0.00% 0

Puts Options of NRBO for (Expired in 37 days)

Strike Price Change % Change Volume
favorite
0
0.00 0.00 0.00% 0
favorite
0
0.00 0.00 0.00% 0
favorite
0
0.00 0.00 0.00% 0
favorite
2.50
0.00 0.00 0.00% 0
favorite
5.00
0.00 0.00 0.00% 0
favorite
7.50
0.00 0.00 0.00% 0
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Cap:    |  Volume (24h):